Authors/Disclosures
|
Nathan P. Staff, MD, PhD, FAAN
(Mayo Clinic)
|
Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health. |
|
JaNean Engelstad
|
JaNean Engelstad has nothing to disclose. |
|
Chamindra G. Laverty, MD
(UC San Diego)
|
The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne. |
|
Peter J. Dyck, MD, FAAN
(Mayo Clinic)
|
Dr. Dyck has nothing to disclose. |
|
Zurab Nadareishvili, MD, PhD
(George Washington University, Department of Neurology)
|
No disclosure on file |